Registro:

Referencias:

• Lanier, L.L., Evolutionary struggles between NK cells and viruses (2008) Nat. Rev. Immunol., 8, pp. 259-268
• Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G., Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs (2004) Proc. Natl. Acad. Sci. USA, 101, pp. 16606-16611
• Martin-Fontecha, A., Thomsen, L.L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., Sallusto, F., Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming (2004) Nat. Immunol., 5, pp. 1260-1265
• Girart, M.V., Fuertes, M.B., Domaica, C.I., Rossi, L.E., Zwirner, N.W., Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12 (2007) J. Immunol., 179, pp. 3472-3479
• Lanier, L.L., Up on the tightrope: natural killer cell activation and inhibition (2008) Nat. Immunol., 9, pp. 495-502
• Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., Moretta, L., NK cells at the interface between innate and adaptive immunity (2008) Cell Death Differ., 15, pp. 226-233
• Chaix, J., Tessmer, M.S., Hoebe, K., Fuseri, N., Ryffel, B., Dalod, M., Alexopoulou, L., Priming of NK cells by IL-18 (2008) J. Immunol., 181, pp. 1627-1631
• Kastelein, R.A., Hunter, C.A., Cua, D.J., Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation (2007) Annu. Rev. Immunol., 25, pp. 221-242
• Vignali, D.A., Kuchroo, V.K., IL-12 family cytokines: immunological playmakers (2012) Nat. Immunol., 13, pp. 722-728
• Pflanz, S., Timans, J.C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells (2002) Immunity, 16, pp. 779-790
• de Groot, R., van Beelen, A.J., Bakdash, G., Taanman-Kueter, E.W., de Jong, E.C., Kapsenberg, M.L., Viral dsRNA-activated human dendritic cells produce IL-27, which selectively promotes cytotoxicity in naive CD8+ T cells (2012) J. Leukoc. Biol., 92, pp. 605-610
• Molle, C., Nguyen, M., Flamand, V., Renneson, J., Trottein, F., De Wit, D., Willems, F., IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3 (2007) J. Immunol., 178, pp. 7607-7615
• Takeda, A., Hamano, S., Yamanaka, A., Hanada, T., Ishibashi, T., Mak, T.W., Yoshimura, A., Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment (2003) J. Immunol., 170, pp. 4886-4890
• Lucas, S., Ghilardi, N., Li, J., de Sauvage, F.J., IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 15047-15052
• Hibbert, L., Pflanz, S., De Waal Malefyt, R., Kastelein, R.A., IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells (2003) J. Interferon Cytokine Res., 23, pp. 513-522
• Owaki, T., Asakawa, M., Morishima, N., Hata, K., Fukai, F., Matsui, M., Mizuguchi, J., A role for IL-27 in early regulation of Th1 differentiation (2005) J. Immunol., 175, pp. 2191-2200
• Cox, J.H., Kljavin, N.M., Ramamoorthi, N., Diehl, L., Batten, M., Ghilardi, N., IL-27 promotes T cell-dependent colitis through multiple mechanisms (2011) J. Exp. Med., 208, pp. 115-123
• Neufert, C., Becker, C., Wirtz, S., Fantini, M.C., Weigmann, B., Galle, P.R., Neurath, M.F., IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 (2007) Eur. J. Immunol., 37, pp. 1809-1816
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991
• Schneider, R., Yaneva, T., Beauseigle, D., El-Khoury, L., Arbour, N., IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells (2011) Eur. J. Immunol., 41, pp. 47-59
• Hu, P., Hu, H.D., Chen, M., Peng, M.L., Tang, L., Tang, K.F., Matsui, M., Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma (2009) Mol. Immunol., 46, pp. 1654-1662
• Liu, L., Wang, S., Shan, B., Shao, L., Sato, A., Kawamura, K., Li, Q., IL-27-mediated activation of natural killer cells and inflammation produced antitumour effects for human oesophageal carcinoma cells (2008) Scand. J. Immunol., 68, pp. 22-29
• Matsui, M., Kishida, T., Nakano, H., Yoshimoto, K., Shin-Ya, M., Shimada, T., Nakai, S., Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity (2009) Cancer Res., 69, pp. 2523-2530
• Oniki, S., Nagai, H., Horikawa, T., Furukawa, J., Belladonna, M.L., Yoshimoto, T., Hara, I., Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma (2006) Cancer Res., 66, pp. 6395-6404
• Wei, J., Xia, S., Sun, H., Zhang, S., Wang, J., Zhao, H., Wu, X., Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells (2013) J. Immunol., 191, pp. 500-508
• Laroni, A., Gandhi, R., Beynon, V., Weiner, H.L., IL-27 imparts immunoregulatory function to human NK cell subsets (2011) PLoS One, 6, p. e26173
• Frank, D.A., Mahajan, S., Ritz, J., Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling (1999) Nat. Med., 5, pp. 444-447
• Kataoka, T., Takaku, K., Magae, J., Shinohara, N., Takayama, H., Kondo, S., Nagai, K., Acidification is essential for maintaining the structure and function of lytic granules of CTL. Effect of concanamycin A, an inhibitor of vacuolar type H(+)-ATPase, on CTL-mediated cytotoxicity (1994) J. Immunol., 153, pp. 3938-3947
• Wang, R., Jaw, J.J., Stutzman, N.C., Zou, Z., Sun, P.D., Natural killer cell-produced IFN-gamma and TNF-alpha induce target cell cytolysis through up-regulation of ICAM-1 (2012) J. Leukoc. Biol., 91, pp. 299-309
• Hunter, C.A., Kastelein, R., Interleukin-27: balancing protective and pathological immunity (2012) Immunity, 37, pp. 960-969
• Yoshida, H., Nakaya, M., Miyazaki, Y., Interleukin 27: a double-edged sword for offense and defense (2009) J. Leukoc. Biol., 86, pp. 1295-1303
• Bosmann, M., Ward, P.A., Modulation of inflammation by interleukin-27 (2013) J. Leukoc. Biol., 94, pp. 1159-1165
• Murugaiyan, G., Saha, B., IL-27 in tumor immunity and immunotherapy (2013) Trends Mol. Med., 19, pp. 108-116
• Iyer, S.S., Ghaffari, A.A., Cheng, G., Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages (2010) J. Immunol., 185, pp. 6599-6607
• Pirhonen, J., Siren, J., Julkunen, I., Matikainen, S., IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages (2007) J. Leukoc. Biol., 82, pp. 1185-1192
• Kalliolias, G.D., Gordon, R.A., Ivashkiv, L.B., Suppression of TNF-alpha and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27 (2010) J. Immunol., 185, pp. 7047-7056
• Tanida, S., Yoshitomi, H., Ishikawa, M., Kasahara, T., Murata, K., Shibuya, H., Ito, H., IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration (2011) Cytokine, 55, pp. 237-244
• Schmidt, C., Giese, T., Ludwig, B., Mueller-Molaian, I., Marth, T., Zeuzem, S., Meuer, S.C., Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis (2005) Inflamm. Bowel Dis., 11, pp. 16-23
• Zeitvogel, J., Werfel, T., Wittmann, M., IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cells (2012) Exp. Dermatol., 21, pp. 426-430
• Cocco, C., Pistoia, V., Airoldi, I., Anti-leukemic properties of IL-12, IL-23 and IL-27: differences and similarities in the control of pediatric B acute lymphoblastic leukemia (2012) Crit. Rev. Oncol. Hematol., 83, pp. 310-318
• Liu, Z., Liu, J.Q., Talebian, F., Wu, L.C., Li, S., Bai, X.F., IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells (2013) Eur. J. Immunol., 43, pp. 468-479
• Ferlazzo, G., Tsang, M.L., Moretta, L., Melioli, G., Steinman, R.M., Munz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells (2002) J. Exp. Med., 195, pp. 343-351
• Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G.M., Marcenaro, S., Dondero, A., Lazzeri, E., Expression of the DNAM-1 ligands, nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction (2006) Blood, 107, pp. 2030-2036
• Chijioke, O., Munz, C., Dendritic cell derived cytokines in human natural killer cell differentiation and activation (2013) Front. Immunol., 4, p. 365
• Ortaldo, J.R., Winkler-Pickett, R., Wigginton, J., Horner, M., Bere, E.W., Mason, A.T., Bhat, N., Regulation of ITAM-positive receptors: role of IL-12 and IL-18 (2006) Blood, 107, pp. 1468-1475
• Tassi, I., Cella, M., Presti, R., Colucci, A., Gilfillan, S., Littman, D.R., Colonna, M., NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion (2008) Blood, 112, pp. 4109-4116
• Kondadasula, S.V., Roda, J.M., Parihar, R., Yu, J., Lehman, A., Caligiuri, M.A., Tridandapani, S., Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma (2008) Blood, 111, pp. 4173-4183
• Charlot-Rabiega, P., Bardel, E., Dietrich, C., Kastelein, R., Devergne, O., Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells (2011) J. Biol. Chem., 286, pp. 27350-27362
• Hasenkamp, J., Borgerding, A., Wulf, G., Uhrberg, M., Jung, W., Dingeldein, S., Truemper, L., Resistance against natural killer cell cytotoxicity: analysis of mechanisms (2006) Scand. J. Immunol., 64, pp. 444-449
• Eissens, D.N., Van Der Meer, A., Van Cranenbroek, B., Preijers, F.W., Joosten, I., Rapamycin and MPA, but not CsA, impair human NK cell cytotoxicity due to differential effects on NK cell phenotype (2010) Am. J. Transplant., 10, pp. 1981-1990
• Orange, J.S., Brodeur, S.R., Jain, A., Bonilla, F.A., Schneider, L.C., Kretschmer, R., Nurko, S., Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations (2002) J. Clin. Invest., 109, pp. 1501-1509
• Horova, V., Hradilova, N., Jelinkova, I., Koc, M., Svadlenka, J., Brazina, J., Klima, M., Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes (2013) FEBS J., 280, pp. 3436-3450
• Zhang, Y., Zhang, B., TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5 (2008) Mol. Cancer Res., 6, pp. 1861-1871
• Semino, C., Angelini, G., Poggi, A., Rubartelli, A., NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1 (2005) Blood, 106, pp. 609-616
• Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., Glimcher, L.H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells (2002) Science, 295, pp. 338-342
• Yu, J., Wei, M., Boyd, Z., Lehmann, E.B., Trotta, R., Mao, H., Liu, S., Transcriptional control of human T-BET expression: the role of Sp1 (2007) Eur. J. Immunol., 37, pp. 2549-2561
• Matsuda, J.L., George, T.C., Hagman, J., Gapin, L., Temporal dissection of T-bet functions (2007) J. Immunol., 178, pp. 3457-3465
• Rossi, L.E., Avila, D.E., Spallanzani, R.G., Ziblat, A., Fuertes, M.B., Lapyckyj, L., Croci, D.O., Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression (2011) J. Leukoc. Biol., 91, pp. 321-331

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------